Ocular Therapeutix, Inc.
OCUL
$7.45
-$0.49-6.17%
| Weiss Ratings | OCUL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | OCUL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | OCUL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.26 | |||
| Price History | OCUL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.19% | |||
| 30-Day Total Return | -1.32% | |||
| 60-Day Total Return | -17.41% | |||
| 90-Day Total Return | -27.46% | |||
| Year to Date Total Return | -14.76% | |||
| 1-Year Total Return | -21.08% | |||
| 2-Year Total Return | 53.29% | |||
| 3-Year Total Return | 41.10% | |||
| 5-Year Total Return | 60.22% | |||
| 52-Week High % Change | -32.57% | |||
| 52-Week Low % Change | 95.57% | |||
| Price | OCUL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $11.78 | |||
| 52-Week Low Price | $4.06 | |||
| 52-Week Low Price (Date) | Apr 26, 2024 | |||
| 52-Week High Price (Date) | Oct 28, 2024 | |||
| Valuation | OCUL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.26B | |||
| Enterprise Value | 946.32M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.26 | |||
| Earnings Per Share Growth | 0.56% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 20.94 | |||
| Price/Book (Q) | 3.97 | |||
| Enterprise Value/Revenue (TTM) | 14.85 | |||
| Price | $7.45 | |||
| Enterprise Value/EBITDA (TTM) | -5.63 | |||
| Enterprise Value/EBIT | -5.51 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | OCUL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 168.02M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | OCUL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 781 357 4000 | |||
| Address | 15 Crosby Drive Bedford, MA 01730 | |||
| Website | www.ocutx.com | |||
| Country | United States | |||
| Year Founded | 2006 | |||
| Profitability | OCUL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -269.57% | |||
| Profit Margin | -303.67% | |||
| Management Effectiveness | OCUL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -30.24% | |||
| Return on Equity | -- | |||
| Income Statement | OCUL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 63.72M | |||
| Total Revenue (TTM) | 63.72M | |||
| Revenue Per Share | $0.38 | |||
| Gross Profit (TTM) | -69.54M | |||
| EBITDA (TTM) | -167.99M | |||
| EBIT (TTM) | -171.78M | |||
| Net Income (TTM) | -193.51M | |||
| Net Income Avl. to Common (TTM) | -193.51M | |||
| Total Revenue Growth (Q YOY) | 15.41% | |||
| Earnings Growth (Q YOY) | -65.60% | |||
| EPS Diluted (TTM) | -1.26 | |||
| EPS Diluted Growth (Q YOY) | 16.79% | |||
| Balance Sheet | OCUL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 392.10M | |||
| Cash Per Share (Q) | $2.33 | |||
| Total Current Assets (Q) | 440.99M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 315.34M | |||
| Current Ratio (Q) | 10.664 | |||
| Book Value Per Share (Q) | $2.00 | |||
| Total Assets (Q) | 457.94M | |||
| Total Current Liabilities (Q) | 41.35M | |||
| Total Debt (Q) | 75.78M | |||
| Total Liabilities (Q) | 142.59M | |||
| Total Common Equity (Q) | 315.34M | |||
| Cash Flow | OCUL - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.29M | |||
| Cash from Financing (TTM) | 332.11M | |||
| Net Change in Cash (TTM) | 196.15M | |||
| Levered Free Cash Flow (TTM) | -86.59M | |||
| Cash from Operations (TTM) | -134.68M | |||
